|Day Low/High||72.66 / 73.69|
|52 Wk Low/High||50.71 / 75.86|
Doug Kass shares his thoughts on how he had one of his best days in recent memory, and warns you not to look in the rear view mirror.
Doug Kass shares his thoughts on animal spirits, and discusses his astonishment at some rising optimism.
What were these places thinking?
The S&P 500 moves higher on Friday as financials benefit from better-than-expected earnings from Bank of America and JPMorgan Chase.
European competition commissioner Margarethe Vestager is still looking into the planned merger of agrochemical companies Dow and DuPont.
Doug Kass shares his thoughts on how January has a lot of nonsense, and reviews his investment troops.
Doug Kass shares his thoughts on the deepening of retail stocks' weakness and the Amazon Effect.
In highlights from this week's trading diary and posts, Kass tells us about how the market's optimism is misplaced and how to make a strategy from retail's wreckage.
Doug Kass shares his thoughts on what was good, bad and ugly in this short, last week of the year.
Doug Kass shares his thoughts on the post-fact investment world and delivers his verdict on Caterpillar.
Doug Kass shares his thoughts on divergences in the market's armor and observes that real tech regulation is complicated.
Doug Kass shares his thoughts on China and life insurers.
Jim Cramer tells people to stay informed and stay focused on next week's game plan.
This number is arbitrary, but for those who have latched onto it, here is a possible scenario that could get us there.
Leading microbiology and life sciences company to combine with global microbial detection and diagnostics business
Doug Kass shares his thoughts on how volatility is now underpriced.
Doug Kass shares his thoughts on managing and selecting short-term trades.
Wall Street is on track to smash closing records on Thursday as a broad rally among stocks resumes.
Patient investors should consider a decline to $71 or $70 as a low-risk entry point.
Doug Kass shares his thoughts on a strange, possibly ominous day, and a 'ludicrous forecast.'
Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.
Doug Kass shares his thoughts on the Trump world and how large-cap biotechs are doing.
Doug Kass shares his thoughts on how faster growth won't be easy and how the debt and deficits are out of control.
Doug Kass shares his thoughts on contrariness and his takeaways and observations on the market.
European and U.S. regulators must still approve of the deal between two of the world's three biggest companies.